An AYA’s Journey Through AML, Academia, and Advocacy

At the young age of 21, just a few weeks into my first semester of grad school, life took a drastic turn. A diagnosis that no one expects—Acute Myeloid Leukemia (AML) with the FLT3 mutation. In the midst of textbooks and lectures, my world shifted to hospital rooms and treatment plans. The words “you have cancer” reverberated in my ears, altering the trajectory of my life.